Adicet Bio, Inc. Share Price
ACETAdicet Bio, Inc. Stock Performance
Open $7.83 | Prev. Close $8.10 | Circuit Range N/A |
Day Range $7.83 - $7.92 | Year Range $0.46 - $9.39 | Volume 1,044 |
Average Traded $7.90 |
Adicet Bio, Inc. Share Price Chart
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jul-26 | $7.83 | $7.92 | +0.00% |
20-Jul-26 | $7.83 | $7.92 | -2.22% |
17-Jul-26 | $8.27 | $8.10 | -0.61% |
16-Jul-26 | $8.50 | $8.15 | -6.43% |
15-Jul-26 | $8.48 | $8.71 | -1.36% |
14-Jul-26 | $8.86 | $8.83 | +0.46% |
13-Jul-26 | $8.81 | $8.79 | -1.79% |